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ABSTRACT
Background Tobacco use kills half a million people
every month, most in low–middle income countries
(LMICs). There is an urgent need to identify potentially
low-cost, scalable tobacco cessation interventions for
these countries.
Objective To evaluate a brief community outreach
intervention delivered by health workers to promote
tobacco cessation in India.
Design Cluster-randomised controlled trial.
Setting 32 low-income administrative blocks in Delhi,
half government authorised (‘resettlement colony’) and
half unauthorised (‘J.J. cluster’) communities.
Participants 1213 adult tobacco users.
Interventions Administrative blocks were computer
randomised in a 1:1 ratio, to the intervention (16
clusters; n=611) or control treatment (16 clusters;
n=602), delivered and assessed at individual level
between 07/2012 and 11/2013. The intervention was
single session quit advice (15 min) plus a single training
session in yogic breathing exercises; the control condition
comprised very brief quit advice (1 min) alone. Both
were delivered via outreach, with contact made though
household visits.
Measurements The primary outcome was 6-month
sustained abstinence from all tobacco, assessed
7 months post intervention delivery, biochemically
veriﬁed with salivary cotinine.
Results The smoking cessation rate was higher in the
intervention group (2.6% (16/611)) than in the control
group (0.5% (3/602)) (relative risk=5.32, 95% CI 1.43
to 19.74, p=0.013). There was no interaction with type
of tobacco use (smoked vs smokeless). Results did not
change materially in adjusted analyses, controlling for
participant characteristics.
Conclusions A single session community outreach
intervention can increase tobacco cessation in LMIC. The
effect size, while small, could impact public health if
scaled up with high coverage.
Trial registration number ISRCTCN23362894.
INTRODUCTION
Tobacco use causes six million premature deaths
each year, most in low-income and middle-income
countries (LMICs),1 and one million in India
alone.2 Even small increases in long-term tobacco
cessation rates can have an important public health
impact.3 Combatting the tobacco epidemic requires
a comprehensive, global strategy including taxation,
smoke-free policies, and dedicated healthcare ser-
vices to encourage and support cessation.4
However, implementation in LMICs has been
limited, hampered by weak regulatory and enforce-
ment infrastructure.5 Cheap, scalable tobacco cessa-
tion interventions that build on existing
infrastructure could strengthen tobacco control in
the Indian context.6
Brief opportunistic advice from a health worker
has been found to be a highly cost-effective inter-
vention to promote smoking cessation in high-
income countries (HICs),7 increasing 12-month
quit rates by one to three percentage points8 and
offering assistance is an important part of the
process.9 However, there is limited evidence on the
effectiveness of quit advice in LMICs, from non-
physicians, or for smokeless tobacco use. These
represent important gaps in the evidence base.
Key messages
What is the key question?
▸ Does a potentially low-cost and scalable
community-outreach intervention, single
session advice (15 min) to stop tobacco use
combined with training in yogic breathing
exercise, increase abstinence rates from tobacco
use in the context of a low–middle income
country (LMIC) compared with very brief quit
advice (1 min) alone?
What is the bottom line?
▸ A simple, cheap and potentially scalable
community-outreach intervention increases
smoked and smokeless tobacco cessation in
India, producing an effect size similar to that of
brief physician advice in high-income countries.
Why read on?
▸ Given the number of tobacco users and limited
resources in LMIC, there is a need to develop
cheap and scalable interventions to combat
tobacco use and, to our knowledge, this is the
ﬁrst trial to establish the effectiveness of a
single session community outreach intervention
to stop tobacco use in low-income communities
in any LMIC worldwide.
Sarkar BK, et al. Thorax 2016;0:1–7. doi:10.1136/thoraxjnl-2016-208732 1
Smoking
 Thorax Online First, published on October 5, 2016 as 10.1136/thoraxjnl-2016-208732
Copyright Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& BTS) under licence. 
group.bmj.com on October 5, 2016 - Published by http://thorax.bmj.com/Downloaded from 
This paper attempts to ﬁll these gaps, evaluating an intervention
of single session smoked and smokeless tobacco cessation advice
plus a single session of yogic breathing exercises, delivered by
healthcare professionals via community outreach in India.
Tobacco use, a major cause of health inequalities, is more
prevalent and quit success rates are lower in deprived groups.10
Even within poorer countries, there is a gradient in tobacco
use.11 While there is a need to improve support across all soci-
etal strata in LMICs, arguably, it is particularly important to
focus on low-income communities within those countries by
outreach to involve tobacco users who would not otherwise
come into contact with health services.6
Given limited resources, and a lack of affordable pharmaco-
therapy with proven effectiveness for smokeless tobacco users,
providing assistance presents a challenge in LMICs such as India
with more smokeless tobacco users than smokers.12 A promising
and culturally appropriate option in this context is the use of
yogic breathing exercises, known as ‘Pranayama’. These are easy
to learn and practice, and there is preliminary evidence they can
reduce cigarette cravings13 14 and promote quitting.15 We there-
fore developed a brief community outreach intervention that
included training on simple breathing exercises to control crav-
ings to aid cessation.
Ideally, an evaluation of a multi-component intervention
would involve multiple experimental conditions allowing deter-
mination of active components. Unfortunately, with limited
resources the main priority is to ﬁnd an intervention that works.
Understanding how it can be optimised can be done once this
‘base camp’ has been established. Therefore we opted for a
pragmatic, effectiveness trial of an intervention compared with
the closest to ‘usual care’ that was ethically acceptable, under-
taken in conditions mimicking what is feasible in routine prac-
tice. Cluster rather than individual randomisation was chosen to
minimise risk of contamination given the close-knit nature of
these communities. Both treatment delivery and assessment
were at an individual level. Following guidelines on complex
intervention development and evaluation,16 this study built on
the extensive work on brief advice from HIC, and proof of
concept studies on breathing exercises as well as ﬁeld studies in
this particular setting.17 Speciﬁcally, the present study sought to
answer the following research question: how effective is single
session quit advice (15 min) with instruction on simple breath-
ing exercises compared with very brief advice (VBA) alone
(1 min) in promoting tobacco cessation when delivered by out-
reach workers in low-income communities in India?
METHODS
Study design
This pragmatic, cluster-randomised controlled trial set in low-
income communities (urban slums) compared two treatments:
the intervention arm included a single face-to-face session of
quit advice plus a single training session on yogic breathing
exercises (BA-YBE); the control arm comprised VBA alone.
Assessments were performed at baseline (immediately before
treatment delivery), 4 weeks and 7 months after delivery of the
treatments. The study was approved by the UCL (3051/002)
and Public Health Foundation of India (TRC-IEC-122/11)
ethics committees.
Participants
Eligible participants were any current, daily, adult tobacco user
aged 23 years or above, living in selected low-income communi-
ties, who provided consent to participate. Recruitment into the
study started in July 2012 and the trial concluded in November
2013. The proposed study area contained approximately 36 000
adults living in 32 randomly selected administrative blocks of
large communities spread over a wide geographical area in
Delhi, India. These low-income communities had been selected
for a previous tobacco study conducted among youths aged 10–
19 years in 2009,18 therefore only adults aged 23 or above were
eligible to avoid contamination with the previous study.
Intervention
Participants in the intervention condition received a single
session of tobacco quit advice lasting an average of 15 min, and
short training in two yogic breathing exercises. The quit advice
contained behaviour change techniques which have been shown
to improve quit rates,19 including coping training, medication
advice, social support and relapse prevention. Two breathing
exercises which are easy to learn and practise, ‘Kapalbhati’
(normal deep inhalation-forceful exhalation) and ‘Anulom
vilom’ (alternate nostril breathing), were chosen as they are cul-
turally appropriate and have been shown to control cravings.14
A written standard operating procedure was followed by the
research team, including a script for quit advice and a standard
video for training on yogic breathing exercises to increase ﬁdel-
ity. Further details are available in the published protocol.20
Control
Whilst a control condition with no advice on tobacco use
(‘usual care’) would be preferable to assess the full intervention
effect, this was considered unethical. Therefore a single control
session involving very brief quit advice21 was used. This pro-
vided verbal information about the harmful effects of tobacco
use and advice to stop tobacco use and lasted on average 1 min.
Procedure, randomisation and masking
A census survey of adults in urban low-income communities of
Delhi was conducted to establish an appropriate sampling frame
for this study.17 As low-income blocks in the study area are
stratiﬁed into two community types (government authorised
‘resettlement colonies’ and unauthorised settlements called
‘Jhuggi-Jhopri’ or ‘JJ clusters’), an equal number of both were
identiﬁed for inclusion. The clusters were identiﬁed and a list of
all eligible tobacco users ﬁnalised within each cluster prior to
randomisation of clusters to the intervention or control arm.
The random sequence was computer generated and blocked to
ensure equal numbers of each community type in the interven-
tion and control conditions. Based on the random sequence, 16
clusters (8 from each community type) were allocated to the
treatment (BA-YBE) and control (VBA) arm, respectively. While
participants were blind to allocation, being a cluster-randomised
trial, concealment of allocation to the research team was not
feasible.
The baseline interview was conducted at the doorstep of
potential participants and those identiﬁed as tobacco users were
invited to participate. Each cluster was divided into three to
four geographical parts (streets/lanes/outer/inner) comprising an
equal number of households from which an equal number of
participants were approached. Those willing to provide consent
were checked for eligibility and formal written consent was
obtained. In the case of multiple eligible participants in the
same household, the ﬁrst consenting tobacco user identiﬁed in
the sampling frame was recruited.
The treatment delivery team consisted of two members, a
medical graduate researcher (physician) and a ﬁeld investigator
(community health worker) trained and initially supervised by
the medical graduate researcher. The intervention was delivered
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by either of them. The ﬁeld investigators were given 1 day f
classroom training for intervention delivery using standard tools
like a script for quit advice and use of a standard video for
training in yogic breathing exercises. All content was delivered
face to face in non-technical, local language (Hindi) in both
groups. Follow-up visits comprised face-to-face interviews at the
residence of participants, 4 weeks and 7 months after the base-
line visit. Due to cluster randomization, blinding was not feas-
ible but follow-up was carried out by a different team of ﬁeld
investigators.
Measures
All measures, including outcome measures, were pre-speciﬁed
and deﬁned in the ISRCTN Registry and published protocol.20
The primary outcome measure, 6-month sustained abstinence,
was deﬁned as per Russell Standard (RS) criteria,22 allowing a
maximum of ﬁve instances of tobacco use (in whichever form)
in the 6 months preceding the follow-up conducted 7 months
after treatment delivery, and was biochemically validated. As the
sample included smokeless and smoked tobacco users, salivary
cotinine was used to detect tobacco exposure, assessed by ELISA
with a cut-off of 20 ng/mL, equivalent to the 13 ng/mL used for
the gas chromatography mass spectrometry method.23
Self-reported abstainers above the cut-off were considered to be
continuing tobacco users as were participants lost to follow-up,
in accordance with the intention-to-treat principle and RS cri-
teria.22 Nicotine replacement therapy (NRT) and other medica-
tion use was assessed at follow-up to exclude false-positive
cotinine results.
The secondary outcome measure was 7-day biochemically
validated point prevalence abstinence assessed 7 months after
treatment delivery. At the 4-week follow-up, all participants
were asked whether they had used tobacco in the past 7 days
(7-day point prevalence), and intervention group participants
were also asked how often they had used the yogic breathing
exercises and how useful they had found them on a seven-point
scale, ranging from ‘not at all’ to ‘very helpful’.
At baseline, standard socio-demographic and smoking
characteristics were assessed. In addition to age, sex and marital
status, participants were asked about employment status
(employed vs other), highest educational attainment (at least
primary education vs not), caste (lower caste vs other) and
household income (≤5000 vs >5000 rupees/month).
Participants were asked when they started tobacco use, depend-
ence (assessed with the heaviness of smoking index,24 modiﬁed
for smokeless tobacco users), quit attempts in the past year,
length of the attempt and whether support was used as well as
how conﬁdent they felt about stopping smoking on a seven-
point scale ranging from ‘not at all conﬁdent’ to ‘very conﬁ-
dent’. Lastly, adverse and serious adverse events were monitored
and recorded by the medical graduate researcher throughout the
study.
Sample size
The initial power calculation based on 32 clusters indicated that
31 participants per cluster would be needed for 90% power to
detect a 5% difference in quit rates between the treatment and
control group in two-tailed analysis (7% vs 2%).20 The effect
estimate was based on early, similar work25 and assumed an
intra-cluster correlation co-efﬁcient (ICC) of 0.01, typical in this
kind of study, and a design effect of 1.24 to account for cluster
randomisation. However, as low-intensity interventions can
have substantial attrition rates (in trials using evidence-based
methods to increase response rates, dropout rates of 20–25% at
6-month follow-up are common)26 which reduces the power to
detect effects in an intention-to-treat design27 and due to the
uncertainty around the ICC estimate, we over-recruited by 20%
per cluster (37.2 participants, rounded up to 38 participants),
resulting in a ﬁnal target sample size of 1216 (38×32 clusters).
This sample size also provided 90% power to detect a larger
difference (8%) in subgroup analyses.
Analysis
Primary and secondary smoking cessation outcomes and base-
line group differences were analysed with a mixed-effects log-
binomial or linear regression with appropriate link functions for
categorical (log/logit-binomial) and continuous (identity
Gaussian) outcome variables using the ‘lme4’ package in R
(V.3.2.0) (Bates DM. lme4: Mixed-effects modelling with R:
Springer, 2010) to account for clustered observations, which is
preferable to the protocol-speciﬁed complex samples analysis.28
All other analyses were conducted in STATA (V.13.1). Results
from the conditional/cluster-speciﬁc models were conﬁrmed
with marginal/population-averaged models using generalised
estimating equations (‘xtgee’ command) with an exchangeable
correlation matrix to account for clustering,29 and ICC was
determined using the analysis of variance method.30
In planned subgroup analyses, intervention by participant
(smoked vs smokeless tobacco and dual product users) and inter-
vention by provider (trained health professional vs trained ﬁeld
health workers) interaction terms were included in models to
assess homogeneity of the effect across these subgroups. In sen-
sitivity analysis, we analysed only those who actually received
the treatment and effect estimates were adjusted for covariates
to account for chance imbalances in baseline characteristics
between intervention and control conditions. Signiﬁcance levels
for multiple comparisons were adjusted with the
Benjamini-Hochberg procedure.31 The study was registered
with the International Standard Randomised Controlled Trial
Number Registry (number ISRCTCN23362894).
RESULTS
As shown in ﬁgure 1, 85.9% (1213/1412) of eligible tobacco
users approached between January 2012 and November 2013
agreed to take part in the study; the most common reason for
not taking part was lack of interest. The follow-up rate at ﬁnal
endpoint was high at 95.3% (1158/1213) and did not differ
between arms. There were no differences in baseline character-
istics between those who were and were not followed up.
The sample of tobacco users recruited was largely male,
middle aged, married, in employment, with at least a primary
education, most were relatively deprived as measured by house-
hold income and nearly half were from the lower caste (table 1).
There were slightly more tobacco smokers than smokeless
tobacco users; a substantial proportion were dual users. Most
had been using tobacco products for 20 years and were moder-
ately dependent. A ﬁfth had made a quit attempt in the last
year, and past quit attempts had lasted up to 2 months, but very
few had previously used any quit support. Participants were gen-
erally conﬁdent in their ability to quit. There were no chance
imbalances between groups with the exception of caste: signiﬁ-
cantly more participants in the intervention than control group
were lower caste (table 1).
Regarding the primary outcome, 2.6% (16/611) of partici-
pants were continuously abstinent at 6 months as per RS cri-
teria, validated by saliva cotinine. Intention-to-treat analysis
showed that participants in the intervention group were about
ﬁve times more likely to be abstinent at 6 months than those in
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the control group; absolute abstinence rates were increased by
2% (table 2), yielding a number needed to treat of 48 to
produce an additional quitter. This difference did not materially
alter and remained signiﬁcant when controlling for all other
covariates.
Validated 7-day point prevalence at 6 months in the total
sample was marginally higher at 2.0% (24/1213). Participants in
the intervention group were nearly four times more likely to
achieve 7-day abstinence at 6 months than those in the interven-
tion group and as before results did not materially change when
controlling for other covariates (table 2).
Overall self-reported 7-day point prevalence at 4 weeks was
9.3% (113/1213). As with the primary and secondary outcomes,
abstinence rates were signiﬁcantly higher in the intervention
group than the control group, more than doubling (RR 2.03;
95% CI 1.30 to 3.19; p=0.002) to 12.4% (76/611) from 6.1%
(37/602). At 4-week follow-up, 61.1% (373/611) in the inter-
vention group had continued to use the breathing exercises, a
ﬁfth (19.0% (116/611)) on most days. They rated the breathing
exercises as helpful (mean=5.3, SD=1.8). No adverse or serious
adverse events were reported.
In pre-speciﬁed per protocol analyses of the primary
outcome, we analysed data from participants who had actually
received treatment, given that signiﬁcantly more participants in
the intervention group than the control group (3.4% (21/611)
vs 1.2% (7/602); p=0.03) missed their treatment. This did not
alter the effect of the intervention (RR 5.48; 95% CI 1.46 to
20.51; p=0.01). We also included potential effect modiﬁers, the
type of tobacco used (smoked vs smokeless, excluding dual
users), poly-use (dual vs single use) and intervention provider
(trained health professional vs trained ﬁeld health workers), as
interaction terms in the main model to assess whether effects
differed between these groups. There was no evidence that type
of product used (pinteraction=0.32), poly-use (pinteraction=0.85)
or the intervention provider (pinteraction=0.90) affected the
outcome.
DISCUSSION
In a trial of tobacco users from low-income communities in
India, 6-month sustained biochemically veriﬁed abstinence rates
were increased ﬁvefold by a low-cost intervention combining
single session quit advice with yogic breathing exercises when
compared with very brief quit advice alone. The increase of 2%
in absolute quit rates is close to that obtained by other low-
intensity interventions observed in HIC.8 33 34 These results
also compare favourably with previous evaluations of more
intensive interventions in LMIC which roughly double short-
term abstinence rates from tobacco.5 While the absolute quit
rates were lower than expected, this may not only reﬂect the
simplicity of the intervention which did not provide any
pharmacological support but also the broader challenge of
making behaviour change interventions relevant in the context
of extreme deprivation, as has been observed elsewhere.35
However, since it is non-physician based, it is potentially scal-
able in settings like India with an inadequate healthcare delivery
system especially for populations with limited access to physi-
cians or medications. It is noteworthy that the average family
income of participants was £50 per month or less than £2 per
day, which makes even NRT unaffordable unless funded by the
government. At follow-up, use of NRT and other medications
Figure 1 Numbers of participants and clusters enrolled in the study and included in the primary analysis.
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Table 1 Baseline characteristics of participants
Characteristics Total (N=1213)
Intervention (BA-YBA)*
(N=611)
Control (VBA)†
(N=602)
Sociodemographic
% (N) Male 79.7 (966) 77.4 (472) 82.1 (494)
Mean (SD) age in years 46.3 (13.6) 45.2 (12.8) 47.4 (14.2)
% (N) Married/cohabiting‡ 86.4 (1044) 85.2 (517) 87.5 (527)
% (N) In employment§ 70.7 (856) 71.7 (438) 69.7 (418)
% (N) No primary education¶ 35.3 (426) 33.3 (202) 37.3 (224)
% (N) Household income ≥5000 INR/month** 34.1 (403) 35.7 (212) 32.5 (191)
% (N) Lower caste†† 43.8 (512) 50.7 (290) 37.2 (222)
Tobacco use
% (N) Smokers 63.8 (774) 65.0 (397) 62.6 (377)
% (N) Smokeless users 58.5 (710) 58.8 (359) 58.3 (351)
% (N) Dual users 22.3 (271) 23.7 (145) 20.9 (126)
Mean (SD) age started use‡‡ 22.4 (9.6) 22.2 (10.0) 22.6 (9.3)
% (N) Made quit attempt in the previous year§§ 20.0 (229) 22.3 (126) 17.8 (103)
Mean (SD) length of longest quit attempt (in weeks)¶¶ 7.6 (30.0) 7.5 (33.2) 7.8 (26.5)
% (N) Previously used support in a quit attempt*** 3.8 (46) 3.8 (23) 3.8 (23)
Mean (SD) heaviness of smoking index score (0-6)††† 3.0 (1.7) 3.2 (1.6) 2.8 (1.7)
% (N) Usually uses tobacco within 5 min of waking‡‡‡ 38.0 (458) 40.0 (243) 36.0 (215)
Mean (SD) confidence in stopping score (1–7)§§§ 4.4 (1.9) 4.5 (1.9) 4.2 (2.0)
Different pairs of superscript letters indicate a significant group difference (p<0.05) after adjustment for false discovery rate and accounting for clustered nature of data.
*Brief quit advice and yogic breathing exercises.
†Very brief quit advice.
‡Four cases missing/refused to answer.
§Three cases missing/refused to answer.
¶Five cases missing/refused to answer.
**Thirty-two cases missing/refused to answer.
††Forty-five cases missing/refused to answer.
‡‡Twenty-nine cases missing/refused to answer.
§§Sixty-nine cases missing/refused to answer.
¶¶Twenty-six cases missing/refused to answer.
***Seventeen cases missing/refused to answer.
†††Sixteen cases missing/refused to answer.
‡‡‡Nine cases missing/refused to answer.
§§§Eight cases missing/refused to answer (scale from 1 ‘not at all confident’ to 7 ‘very confident’).
Table 2 Effect of intervention on biochemically verified smoking cessation*
Intervention
(BA-YBE)
Control
(VBA)
% (number)
Percentage point
difference
(95% CI)
Intracluster correlation
coefficient
(95% CI)
Model 1: Relative risk†
Model 2: Adj. relative risk‡
Model 3: Adj. relative risk§
(95% CI)
Primary outcome: abstinence
for 6 months¶
2.6 (16/611) 0.5 (3/602) 2.12 (0.74 to 3.51) 0.014 (0.000 to 0.033) Model 1: 5.32 (1.43 to 19.74) **
Model 2: 5.10 (1.46 to 17.84) **
Model 3: 4.54 (1.21 to 17.01) ††
Secondary outcome: point
prevalence at 6 months‡‡
3.1 (19/611) 0.8 (5/602) 2.28 (0.72 to 3.83) 0.014 (0.000 to 0.034) Model 1: 3.77 (1.31 to 10.81) **
Model 2: 3.71 (1.25 to 11.02) §§
Model 3: 2.87 (0.92 to 8.93) ¶¶
*Outcome measures were biochemically verified using saliva cotinine; all participants reporting no tobacco use at final follow-up were asked to provide a saliva samples. Failure to
provide biochemical verification was low (1.2% (14/1213); there were no differences by treatment group) with those not providing saliva samples or lost to follow-up counted as
treatment failures.
†Results from conditional/cluster-specific approach with mixed effects log-binomial regression are presented, using intention to treat analysis based on all participants (N=1213). Results
were confirmed using a marginal/population approach which yielded comparable estimates (primary outcome: 5.33, 95% CI 1.30 to 21.90, p=0.020; secondary outcome: 3.76, 95% CI
1.31 to 10.82, p=0.014).
‡Results from model 1 were adjusted for chance imbalances, including all variables in table 1. Data missing at random were imputed using standard multivariate imputations with
chained equations (MICE) in STATA (‘mi chained’ command with burn in of 100 iterations and 20 imputations) which is more suitable for mixed (dichotomous and continuous)
variables,32 and this analysis is therefore based on all participants (N=1213).
§Results from model 1 were adjusted for chance imbalances, including all variables in table 1. Only participants with complete data were included in the analysis (N=1009).
¶The primary outcome conforms to the Russell Standard guidelines, that is, self-reported abstinence for at least 6 months (with no more than five occasions of tobacco use) and no
tobacco use in the last week, as indicated at final follow-up.
**p=0.01.
††p=0.03.
‡‡The secondary outcome was point prevalence at 6 months defined as complete abstinence in the week prior to follow-up.
§§p=0.02.
¶¶p=0.07.
BA-YBE, brief advice, yogic breathing exercises; VBA, very brief advice.
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for quitting was assessed but not reported by any participants,
likely due to prohibitive costs.36
To our knowledge, this is the ﬁrst trial using a rigorous
design, including longer-term, biochemically validated outcomes
to establish the effectiveness of brief, pro-active quit advice in
low-income communities in any LMIC. Given that community
health workers, who earn around £100–150 per month, were
given just 1 day training to deliver the intervention, that the
intervention was equally effective when provided either by a
community health worker or by a physician researcher and that
total study material costs were below £200, this intervention is
likely to also be highly cost effective at a cost of less than £10
per treated tobacco user.37
This study beneﬁted from assessing an evidence-based and
theory-based intervention using standardised methodology,
including validated longer-term outcomes, extensive prior ﬁeld
work and low attrition rates. A number of factors may have con-
tributed to the effectiveness and reach of the intervention. First,
yogic breathing exercises in addition to reducing cravings,14 pos-
sibly via actions in the insula in the cerebral cortex,38 may also
appeal due to being a novel, culturally acceptable cessation aid
which provides an element of support without the need for
referral or expensive medications. Second, the proactive, con-
venient delivery of the intervention near participants’ homes
may have engaged more tobacco users. Third, the treatment
being free of charge may have drawn in tobacco users, irrespect-
ive of their readiness to quit. Lastly, the advice, being centred
around evidence-based content,19 was tailored to the speciﬁc
cultural context, targeting users of both smoked and smokeless
tobacco, and—as evidenced by very limited smoking-related
knowledge at baseline (not reported here)—provided extensive
details hitherto unknown to participants.
There were some limitations. Since the intervention com-
prised both quit advice and training in yogic breathing exercises,
the effect of speciﬁc intervention components cannot be disso-
ciated. However, the priority at this stage was to identify a
potentially cost-effective, scalable brief community outreach
intervention that included effective, research-based components.
Future factorial studies should further isolate the impact of dif-
ferent intervention components on outcome. The number of
events in this trial was small. Although this is not uncommon in
low-intensity interventions, replication of ﬁndings is warranted.
Lastly, whilst every effort was made to select a random sample,
ﬁndings are necessarily limited to this sample of deprived
tobacco users in Delhi. However, given that outcomes were
comparable to those from a study evaluating a similarly brief,
two-session tobacco use intervention in rural India,39 the results
may be generalised to other geographic locations and LMICs.
Nonetheless, further work should conﬁrm whether this type of
opportunistic, brief quit advice and yogic breathing exercises is
equally effective in other relevant settings, such as schools or
work places, to maximise its potential impact.
In conclusion, we have shown a substantial effect of a poten-
tially inexpensive, scalable, non-physician-dependent, culturally
sensitive intervention to aid cessation of tobacco use in LMICs.
Although the number needed to treat to gain an additional
quitter was high at 48, the low intervention cost and ease of
implementation with limited additional resources (see protocol
for details)20 means that it may offer a credible alternative to
more effective but also more expensive and intensive treatments,
such as pharmacotherapy, with very low coverage, to tackle the
enormous tobacco problem facing disadvantaged users in some
of the poorest countries of the world. Despite the small effect
observed, even minimal changes in tobacco use can have clinical
signiﬁcance.3 Indeed, if this intervention were to be rolled out
across India, it would likely result in several million fewer
tobacco users per year. While further research is needed to
conﬁrm our ﬁndings in different settings, the current trial is
consistent with results from HIC and underlines the great
potential of low-intensity interventions to improve public health
in the speciﬁc context of LMICs.
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